Search
Please see below for a list of search results.
The HTA regulates establishments in England, Wales and Northern Ireland that conduct licensed activities under the Human Tissue Act 2004 (HT Act).
The Human Tissue Authority (HTA) has published licence fee levels for the 2020/21 business year.
The new licence fees come into effect from 1 April 2020, with an increase of 4% on the previous year’s fees.
Today the Human Tissue Authority (HTA) has published licence fee levels for the 2020/21 business year.
The new licence fees come into effect from 1 April 2020, with an increase of 4% on the previous year’s fees.
All establishments licensed under the Human Tissue Act 2004 and the Quality and Safety of Organs Intended for Transplantation Regulations 2012 must review their licensing records and complete a compliance update.
The information collected will be used to:
The Human Tissue Authority (HTA) had announced licence fee levels for the 2018/19 business year. These licence fees came into effect from April 2018 and was calculated on the same basis as 2017/18.
You can read the full sector breakdowns here.
DIs and LHs both play key roles in the licensing arrangements under the Human Tissue Act (2004) and the Q&S Regulations. This section explains the roles and responsibilities of these individuals under the Q&S Regulations. Separate guidance is available on the role of Designated...
The activities of storing and importing human tissues and cells for human application can only be carried out by an establishment holding an appropriate HTA licence.
The following activities may be carried out either under an appropriate HTA licence or under the...